Skip to main content

Want a detailed portfolio tracker?

Shattuck Labs (STTK) P/E (2020 - 2026)

Shattuck Labs (STTK) P/E from Oct 9, 2020 to Jul 21, 2026. The TTM Shattuck Labs (STTK) P/E is -8.86. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Shattuck Labs (STTK)

YearP/EChange
2026-8.86+119.53%
2025-4.04+427.51%
2024-0.77-75.98%
2023-3.19+124.40%
2022-1.42-82.16%
2021-7.96-88.32%
2020-68.09N/A

Comparison Shattuck Labs (STTK) P/E with competitors

Shattuck Labs (STTK) P/E is -8.86.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.84%
FGENFibroGen Inc0.24-102.71%
CHRSCoherus Biosciences Inc0.85-109.58%
FBIOFortress Biotech Inc0.95-110.71%
ORMPOramed Pharmaceuticals Inc1.50-116.96%
AGENAgenus Inc3.01-133.97%
INVAInnoviva Inc3.15-135.60%
VXRTVaxart Inc3.55-140.06%
CRMDCorMedix Inc3.63-140.95%
CVACCureVac N.V.4.45-150.18%
GLPGGalapagos NV4.86-154.84%
SRPTSarepta Therapeutics Inc4.88-155.10%
ABEOAbeona Therapeutics Inc5.39-160.81%
ABUSArbutus Biopharma Corp5.60-163.15%
ZVRAZevra Therapeutics Inc5.89-166.45%
SPROSpero Therapeutics Inc6.23-170.30%
CGENCompugen Ltd6.31-171.26%
RIGLRigel Pharmaceuticals6.87-177.56%
SLXNSilexion Therapeutics Corp7.30-182.35%
OMEROmeros Corporation9.26-204.50%
AUPHAurinia Pharmaceuticals Inc9.58-208.18%
PLXProtalix BioTherapeutics Inc10.89-222.92%
ACADAcadia Pharmaceuticals Inc11.73-232.37%
TBPHTheravance Biopharma Inc12.26-238.40%
ADMAAdma Biologics Inc12.42-240.16%
HRMYHarmony Biosciences Holdings Inc13.82-255.98%
SABSSAB Biotherapeutics Inc14.14-259.55%
NAGENiagen Bioscience Inc14.82-267.24%
INCYIncyte Corp15.82-278.58%
REGNRegeneron Pharmaceuticals Inc15.86-278.97%
PBYIPuma Biotechnology Inc17.32-295.43%
CPRXCatalyst Pharmaceuticals Inc17.44-296.83%
EXELExelixis Inc17.54-297.94%
TGTXTG Therapeutics Inc18.97-314.06%
MDXGMimedx Group Inc20.55-331.96%
XOMAXOMA Royalty Corp22.87-358.18%
ARGXArgen X SE24.30-374.25%
CTMXCytomX Therapeutics Inc24.82-380.15%
XOMAOXOMA Royalty Corp25.34-386.06%
HALOHalozyme Therapeutics Inc25.62-389.21%
XOMAPXOMA Royalty Corp25.67-389.73%
VRTXVertex Pharmaceuticals Inc27.99-415.97%
RPRXRoyalty Pharma plc - Class A28.69-423.79%
SLNOSoleno Therapeutics Inc29.02-427.49%
ASNDAscendis Pharma A/S30.09-439.57%
LGNDLigand Pharmaceuticals Inc - Class B37.91-527.90%
APLSApellis Pharmaceuticals Inc39.02-540.42%
BMRNBiomarin Pharmaceutical Inc42.21-576.43%
KRYSKrystal Biotech Inc45.34-611.78%
ONCBeiGene Ltd69.54-884.89%
PHARPharming Group N.V.75.03-946.80%
TECHBio-Techne Corp101.96-1250.78%
VCELVericel Corp109.92-1340.66%
ALNYAlnylam Pharmaceuticals Inc117.96-1431.44%
GMABGenmab140.29-1683.43%
TLXTelix Pharmaceuticals Ltd162.15-1930.18%
CORTCorcept Therapeutics Inc212.86-2502.47%